Innovata Biomed Ltd has developed an alternative device, the Clickhaler®, which is a multiple-dose dry powder inhaler (DPI). The present study compared patient acceptability of the salbutamol ...
Teva has launched a digitally-enabled inhaler in the UK, the first European market for the device, for use by patients with asthma and chronic obstructive pulmonary disorder (COPD). The GoResp ...
Teva has launched new digital inhaler and drug combination in the US, containing built-in sensors that connect to a phone to help manage asthma and COPD symptoms. Israel-based Teva said the ...
Objective: To reanalyze data from two previous studies to provide stronger evidence of benefit for early use of single-dose intravenous bolus salbutamol in children with acute severe exacerbations ...
However for years now, my inhalers will just stop working without warning. Sometimes with 30 puffs left. Sometimes almost full. This is a very dangerous situation, and yet after contacting Teva ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
At the beginning of each treatment period the patient was prescribed, in random order, an inhaler containing either salbutamol (100 μg per activation) or placebo. Both inhalers appeared identical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results